Abstract
Here, we aimed to investigate the associations of comorbidities in HIV patients given antiepileptic drugs. HIV patients given antiepileptic drugs for at least 6 months were considered. Comorbidities of the epileptic, HIV-positive patients were stratified according to patients’ age and causes of epilepsy. Seventy-four of the 97 HIV patients identified had at least one comorbidity. Patients more than 50-years old had more comorbidities (1.9 ± 1.5 vs. 1.1 ± 1.2, p < 0.01) compared with younger subjects. The distribution of the psychiatric disorders was comparable between age-related categories. A marginally significant trend for higher frequency of psychiatric disorders was observed in patients with idiopathic epilepsy versus other causes of epilepsy (43% vs. 24%), Because the presence of comorbid disorders is a major driver for premature mortality both in HIV infection and epilepsy, strategies aimed at favoring prevention, early identification, and adequate treatment in these clinical settings should be pursued at all levels of care.
Similar content being viewed by others
References
Keezer MR, Sisodiya SM, Sander JW. Comorbidities of epilepsy: current concepts and future perspectives. Lancet Neurol. 2016;15:106–15.
Wilner AN, Sharma BK, Soucy A, et al. Common comorbidities in women and men with epilepsy and the relationship between number of comorbidities and health plan paid costs in 2010. Epilepsy Behav. 2014;32:15–20.
Kessler RC, Lane MC, Shahly V, et al. Accounting for comorbidity in assessing the burden of epilepsy among US adults: results from the National Comorbidity Survey Replication (NCS-R). Mol Psychiatry. 2012;17:748–58.
Tellez-Zenteno JF, Patten SB, Jette N, et al. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia. 2007;48:2336–44.
Seidenberg M, Pulsipher DT, Hermann B. Association of epilepsy and comorbid conditions. Future Neurol. 2009;4:663–8.
Jetter GM, Cavazos JE. Epilepsy in the elderly. Semin Neurol. 2008;28:336–41.
Guaraldi G, Orlando G, Zona S, et al. Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011;53:1120–6.
Levy RM, Bredeson DE. Central nervous system diseases in HIV infection. J Acquir Immune Defic Syndr. 1988;1:41–64.
Wong MC, Suite ND, Labar DR. Seizures in human immunodeficiency virus infection. Arch Neurol. 1990;47:640–2.
Kellinghaus C. Frequency of seizures and epilepsy in neurological HIV-infected patients. Seizure. 2008;17:27–33.
Pascual-Sedano B, Iranzo A, Marti-Fabregas J, et al. Prospective study of new-onset seizures in patients with human immunodeficiency virus infection: etiologic and clinical aspects. Arch Neurol. 1999;56:609–12.
Modi M. New onset seizures in HIV. Epilepsia. 2009;50:1266–9.
Cockerham L, Scherzer R, Zolopa A, et al. Association of HIV infection, demographic and cardiovascular risk factors with all-cause mortality in the recent HAART era. J Acquir Immune Defic Syndr. 2010;53:102–6.
Sander JW. Comorbidity and premature mortality in epilepsy. Lancet. 2013;382:1618–9.
Price RW. Neurological complications of HIV infection. Lancet. 1996;348:445–52.
Gervasoni C, Formenti T, Cattaneo D. Management of polypharmacy and drug–drug interactions in HIV patients: a 2-year experience of a multidisciplinary outpatient clinic. AIDS Rev. 2019;21:40–9.
Sone D, Watanabe M, Maikusa N, et al. Reduced resilience of brain gray matter networks in idiopathic generalized epilepsy: a graph-theoretical analysis. PLoS ONE. 2019;14:e0212494.
Gomez-Ibañez A, McLachlan RS, Mirsattari SM, et al. Prognostic factors in patients with refractory idiopathic generalized epilepsy. Epilepsy Res. 2017;130:69–73.
Braga AM, Fujisao EK, Verdade RC, et al. Investigation of the cingulate cortex in idiopathic generalized epilepsy. Epilepsia. 2015;56:1803–11.
Sarkis RA, Pietras AC, Cheung A, et al. Neuropsychological and psychiatric outcomes in poorly controlled idiopathic generalized epilepsy. Epilepsy Behav. 2013;28:370–3.
Cattaneo D, Baldelli S, Giacomelli A, et al. Assessment of antiepileptic drug concentrations in hiv-infected versus HIV-negative patients: a retrospective analysis. Clin Pharmacokinet. 2019;4:1–6.
Cattaneo D, Baldelli S, Resnati C, et al. Evaluation of the concentrations of psychotropic drugs in HIV-infected versus HIV-negative patients: potential implications for clinical practice. World J Biol Psychiatry. 2018;20:1–7.
Acknowledgements
This is an independent, no profit study supported by intramural funding of the L. Sacco Hospital. The Authors have not received any compensation for the present paper. Not related to the present investigation, CG and GR have received educational grants from Merck Sharp & Dome, Janssen-Cilag, ViiV Healthcare, Bristol Myers Squibb, Boehringer Ingelheim, Gilead and Abbvie. DC has received educational grants from Merck Sharp & Dome and ViiV Healthcare.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cattaneo, D., Giacomelli, A., Minisci, D. et al. Association of HIV Infection with Epilepsy and Other Comorbid Conditions. AIDS Behav 24, 1051–1055 (2020). https://doi.org/10.1007/s10461-019-02530-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-019-02530-8